Heme oxygenase (HO) catalyzes the degradation of heme to biliverdin. The crystal structure of human HO-1 in complex with heme reveals a novel helical structure with conserved glycines in the distal helix, providing flexibility to accommodate substrate binding and product release (Schuller, D. J., Wilks, A., Ortiz de Montellano, P. R., and Poulos, T. L. (1999) Nat. Struct. Biol. 6, 860 -867). To structurally understand the HO catalytic pathway in more detail, we have determined the crystal structure of human apo-HO-1 at 2.1 Å and a higher resolution structure of human HO-1 in complex with heme at 1.5 Å. Although the 1.5-Å heme⅐HO-1 model confirms our initial analysis based on the 2.08-Å model, the higher resolution structure has revealed important new details such as a solvent H-bonded network in the active site that may be important for catalysis. Because of the absence of the heme, the distal and proximal helices that bracket the heme plane in the holo structure move farther apart in the apo structure, thus increasing the size of the active-site pocket. Nevertheless, the relative positioning and conformation of critical catalytic residues remain unchanged in the apo structure compared with the holo structure, but an important solvent H-bonded network is missing in the apoenzyme. It thus appears that the binding of heme and a tightening of the structure around the heme stabilize the solvent H-bonded network required for proper catalysis.
molecule through the guanylate cyclase system in a manner similar to nitric oxide, although this remains a controversial topic (4, 5) . Finally, the iron released by HO is normally recycled and represents the major source of this metal in heme homeostasis, whereas increased iron release due to elevated HO activity can trigger enhanced lipid and protein peroxidation (6, 7) . There are two HO isoforms, denoted HO-1 and HO-2 (8 -10) . A third isoform discovered in rats has been described (11) , although the expressed protein is not an active HO, and therefore, its significance is currently unclear.
Mammalian HO-1 is a membrane-bound protein.
The expression of truncated, water-soluble, fully active forms of human (12) and rat (13) HO-1 missing the C-terminal 23-26 amino acid residues has facilitated major advances in structure/function studies of HO, especially mechanistic studies. The mechanism of HO resembles that of cytochrome P450 in its ability to oxidize unactivated C-H bonds (14) . However, in contrast to cytochrome P450 and heme peroxidases, the action of HO does not proceed through a ferryl intermediate (15, 16 ), but appears rather to involve a peroxo ligand capable of attacking the ␣-meso bridge of the heme (Fig. 1) . Furthermore, unlike true hemoproteins, the heme in HO serves as both cofactor and substrate in a "substrate-assisted" reaction. The HO oxidation consumes a total of three molecules of oxygen and 7 electrons (17) and produces CO and free iron (Fe 2ϩ ). For the human HO enzymes, electrons are provided by NADPH-cytochrome P450 reductase (18) , whereas alternative electrons donors are employed in plants and bacteria (19, 20) .
For human HO-1, the expression of even shorter but still active versions of HO-1 facilitated crystallization and structure determination of human HO-1 complexed with heme (21) . The structure reveals a novel protein fold that consists primarily of ␣-helices, with the heme wedged between the distal and proximal helices. Conserved glycines in the distal helix provide flexibility, causing the two HO molecules in the crystallographic unit cell to differ. In one molecule, the active-site pocket is more open, with relatively loose distal helix-heme contact, whereas in the other molecule, contacts between the heme and distal helix are tighter. This, together with the high crystallographic thermal factors, suggests that flexibility of the distal helix enables the heme pocket to be opened and closed to bind the heme substrate and to permit dissociation of the biliverdin product. The crystal structure of a truncated rat HO-1 isoform (22) and, more recently, the structure of a bacterial HO from the Gram-negative pathogenic bacterium Neisseria meningitidis (23) reveal structural information very similar to that of human HO-1.
Recently, the crystallization and three-dimensional structure of rat apoheme oxygenase were published at 2.55 Å (24).
Here we report the human apo-HO-1 structure at 2.1 Å and a high-resolution structure of human HO-1 complexed with heme refined to 1.5 Å. Both higher resolution structures have enabled us to detect important structural features that were not apparent at the lower resolution. We also report the refined structure of the heme⅐HO-1 complex in the B crystal form to 2.6 Å. This form was important for initial phasing of HO (21) .
Although the B form structure is of considerably lower resolution than the C form structure of the heme⅐HO-1 complex, it may be of interest to investigators studying crystal packing. Crystallization-Heme⅐HO-1 complex crystals were grown as previously described (25, 21) using the sitting-drop vapor diffusion method with a well solution of 2.08 M ammonium sulfate, 100 mM HEPES (pH 7.5), and 0.9% 1,6-hexanediol. Drops consisted of protein stock (5 l) at 35 mg/ml in 20 mM potassium phosphate (pH 7.4) mixed with well solution (5 l) on siliconized coverslips. Apo crystals were grown with a well solution of 2.25 M ammonium sulfate, 100 mM HEPES (pH 7.5), and 0.9% 1,6-hexanediol. All crystals were grown at 28°C, although we have recently found that heme⅐HO-1 complex crystals tended to grow as single plates rather than clusters of plates at room temperature. For cryogenic data collection, heme⅐HO-1 crystals were transferred to a solution of 2.32 M ammonium sulfate, 100 mM HEPES (pH 7.5), 0.9% 1,6-hexanediol, and 20% (v/v) glycerol. For apo-HO-1 crystals, D(ϩ)-trehalose was used as the cryoprotectant. Cryogenic data collection involved a seven-step transfer to artificial precipitant solution with an increased D(ϩ)-trehalose concentration up to 35% (v/v). Apo-and holo-HO-1 crystals all belong to the monoclinic space group P2 1 , with the cell dimensions listed in Table I .
MATERIALS AND METHODS

Bacterial Expression and Protein
Data Collection-Apo-HO-1 data and the B form heme⅐HO-1 complex were collected using an in-house R-AXIS IV imaging plate detector equipped with a rotating copper anode x-ray generator with Osmic optics. Crystals were maintained at Ϫ160°C in a steam of nitrogen (Crystal Logic, Los Angeles). For both sets of data collection, a 180°scan using 1°frames was collected. Data collection for the high-resolution C crystal form heme⅐HO-1 complex was carried out at Stanford Synchrotron Radiation Laboratory beamline 7-1 with a Mar345 imaging plate. Optimization of data collection was guided by the STRATEGY function of MOSFLM (26) . All data were reduced using DENZO and SCALE-PACK (27) , with rejections performed using ENDHKL (Louis Sanchez, California Institute of Technology) in conjunction with SCALEPACK.
Model Building and Refinement-The apo-HO-1 structure was determined by the method of molecular replacement using MOLREP (28) . A monomer of the human heme⅐HO-1 crystal structure (Protein Data Bank code 1QQ8) (21) with the heme and waters removed was used as the probe, with searches being carried out at 4.0 Å in space group P2 1 The arrows indicate the location of the water that very likely occupies two positions at fractional occupancy. B, the same as in A, showing the H-bonded network that very likely serves to deliver protons to the iron-linked oxygen required for catalysis. Note that one of these waters is 4.4 Å from the heme ␣-meso-carbon. An iron-liked oxygen/peroxide would very likely displace this water as well as the water liganded to the iron, thus enabling the distal peroxide oxygen atom to directly contact the ␣-meso-carbon.
body-refined and fixed in place, followed by searches for the remaining molecules in the asymmetric unit. A total of four solutions were found, corresponding to the expected four monomers/asymmetric unit. The final R factor was 48.9%, with a correlation coefficient of 54.4%. The structure was further refined in CNS (29) . Protein atoms were initially refined by simulated annealing, followed by a few cycles of conjugate gradient minimization and water picking. Finally, temperature factors were refined. No restraints for non-crystallographic symmetry were applied. The program O (30) was used for further adjustment and modeling of protein atoms, ligands, and water molecules. Backbone geometry was checked in PROCHECK (31) , and none of the residues were in the disallowed region. Data collection and refinement statistics for all structures are summarized in Table I .
The B form heme⅐HO-1 complex initial model was constructed by placing the C crystal form molecules according to the NCS relationships uncovered in the initial molecular replacement (21) . It was then refined in non-crystallographic symmetry (CNS) (29) . For the high-resolution heme⅐HO-1 complex structure, the initial 2.08-Å structure was subjected to rigid-body refinement with the newly collected synchrotron data, followed by minimization and B-factor refinement in CNS (29) . When refinement proceeded to the point where the use of multiple conformations and anisotropic thermal factors was necessary and appropriate, SHELXL (32) was used. TOM was used for model building for both structures (33) . To accommodate model building of the high-resolution structure with multiple conformations and anisotropic thermal factors, XtalView (34) was used.
RESULTS
Structure Solution-Apo-HO-1 crystallizes in two different unit cells, the A and B forms ( Table I ). The B form was produced by growing crystals in 10% glycerol and was used to solve the initial structure of holo-HO-1 (21) . Refinement of the B form apo-HO-1 model was never successful because of inadequate data quality, which led us to further investigate the A form. An empirical approach to molecular replacement was taken with the A crystal form. Rather than using one method, several programs, including AmoRe (35), EPMR (36), BRUTE (37), CNS (29) , and MOLREP (28), were used. Of these, only MOLREP was successful.
Heme⅐HO-1 Structure-The higher resolution 1.5-Å structure of heme⅐HO-1 is basically the same as in our earlier report (21) . However, new details on solvent structure in the active site possibly relevant to the catalytic mechanism are now visible. The relevant region is shown in Fig. 2 . As noted earlier, the two molecules in the asymmetric unit adopt slightly different conformations: one with the active site more "closed" in molecule A and the other more "open" in molecule B. As shown in Fig. 2 , Asp 140 in the closed molecule participates in an H-bonded network involving well ordered solvent molecules. The "peanut" shape electron density indicated by the arrows in changing Asp 140 to Ala converts HO-1 into a peroxidase (39). The reason is that, in the mutant, the peroxide O-O bond is cleaved, giving a traditional peroxidase Fe(IV)-O oxyferryl center (39) . In the normal HO-1 reaction, the distal peroxide atom (Fig. 1) undergoes electrophilic attack on the heme ␣-mesocarbon. One factor that controls which process dominates, normal heme oxidation or cleavage of the O-O bond, is undoubtedly a proper proton delivery mechanism to the iron-linked oxygen. We earlier postulated that the proton donor must be water because there are no active-site residues close enough to serve as a direct proton donor (21) . The Asp
140
-water H-bonded network provides a potential proton delivery system. That the water network is not well defined in the open molecule suggests that the closed molecule is much closer to the active form of HO-1.
Apo Structure-The structure of human apo-HO-1 has been refined in the A crystal form to an R-factor of 0.217 and a free R-factor of 0.262 at 2.1-Å resolution. There are four molecules of apo-HO-1 in the asymmetric unit (designated A-D), in comparison with two molecules in the heme⅐HO-1 structure. The final structure contains a total of 7065 protein atoms, 450 water atoms, and one non-water solvent, assigned as Cl Ϫ . The first 9 -10 and last 10 residues of the 233-residue protein are not ordered in electron density maps for molecules B and D. For molecule A, residues 10 -224 are resolved, whereas for molecule C, we observed, for the first time, the N terminus (Fig. 3A) , although the last 10 residues of the C terminus are disordered. The overall r.m.s. deviation of backbone atoms between the four molecules ranges from 0.38 to 0.55 Å (Table II) . However, there are regions between the molecules where larger deviations (Ͼ0.8 Å) exist and are localized between residues 156 -159 and 188 -195. Table III lists the overall r.m.s. deviation of backbone atoms between the four apo-HO-1 molecules and the two heme⅐HO-1 molecules. At first glance, the r.m.s. deviation between the two sets of structures is also low, suggesting very little structural change. However, closer analysis revealed that one of the heme⅐HO-1 molecules (molecule A/closed molecule) has a higher r.m.s. deviation than the other (molecule B/open molecule) with respect to the four apo-HO-1 molecules. The plot of the r.m.s. deviation for C-␣ atoms between the two holo-HO-1 molecules and the four apo-HO-1 forms (Fig. 4B) shows regions of large deviation in the proximal helix, but only for the closed molecule in the heme⅐HO-1 structure are there large deviations in the distal helix and following loop. Fig. 3 (B and C) shows the superimposition of an apo-HO-1 molecule with the open and closed molecules of human heme⅐HO-1. Therefore, as might be expected, the apo-HO-1 active site more closely matches the open form of heme⅐HO-1.
N-terminal Region-Of the four apo-HO-1 molecules in the asymmetric unit, only in molecule C is the entire N-terminal region seen (Fig. 3A) . In molecule C, the N terminus curls away from the molecule, whereas the location of the corresponding N-terminal region in the heme⅐HO-1 structure (Fig. 3, B and C) and other HO structures (rat HO-1 and bacterial N. meningitidis HO complexed with heme) (22, 23) appears to be different. For the other HO structures, the N-terminal region bends into the molecule, pushing down toward the proximal helix.
Distal Helix-One of the most intriguing features of the HO structures to date is the distortion in the distal helix that covers part of the distal heme surface as well as forms an integral part of the oxygen-binding pocket (21) (22) (23) . Of the three heme⅐HO structures now known, only in human HO-1 has the active site been trapped in the open and closed conformation. In both rat HO-1 and N. meningitidis HO, the distal helix is clearly in a closed conformation (22, 23) .
In the apo-HO-1 structure, the distal helix in all four molecules is clearly in an open conformation (Figs. 5 and 6 ). The backbone atoms of Gly 143 , which, in the closed molecule of the heme⅐HO-1 structure, directly contact the heme, have shifted away in the apo-HO-1 structure. The amide group of Gly 143 is directed away from where the heme would be in all four apo molecules, whereas movement of Gly 139 is moderate in comparison with the shift observed in Gly 143 . Only in molecules A, B, and D is the ␣-carbon of Gly 139 observed shifting away from the heme site, with the carbonyl oxygen only marginally moving away in molecules A and D, but still retaining the same orientation as that in the closed molecule of heme⅐HO-1 (Fig. 5) . These changes are important because the Gly 139 carbonyl oxygen can H-bond with the heme distal water ligand and hence might also interact with oxygen in the oxyheme complex. In- terestingly, the catalytically important Asp 140 discussed above is relatively unchanged in the apo structure, with the exception of the carboxylate side chain, which moves closer to the heme site because of the small upward shift of Gly 139 . Several residues in the distal helix differ between the apo and holo structures. These include Ser 142 , which stabilizes the distal helix distortion through H-bonds with the peptide backbones of Gly 143 and Leu 141 , the ␤-carbon of Leu 141 , the N-atom of Lys 179 , the carboxylate side chain of Glu 145 , and the C-␦1 and carbonyl oxygen atoms of Leu 138 . Despite the change in these residues, the kink in the distal helix is retained in the apo structure. For instance, the redirection of the Gly 143 amide bond stretches contact between itself and the Ser 142 ␤-carbon from 2.91 Å in the closed molecule of the heme⅐HO-1 structure remains intact, the non-bonded contact with the C-␦1 atom of Leu 138 is broken, causing the side chain of Leu 138 to move away from the heme site, thus reorienting the C-␦1 atom by ϳ100°a way from the heme site in all four apo molecules. The carbonyl oxygen of Ser 142 that H-bonds to the carboxylate side chain of Glu 145 is also broken in all four apo molecules. This causes the Glu 145 side chain to rotate and point in the opposite direction in all four apo molecules. In addition, residues following Glu 145 , Val 146 , and Leu 147 have also shifted away from the heme, but maintain a conformation similar to that of the closed molecule in heme⅐HO-1. Not surprisingly, the position of the distal helix and the sequence of residues within this stretch (residues 139 -147) in the apo-HO-1 structure adopt a conformation similar to that of the heme⅐HO-1 open molecule (Fig. 6) . However, the distal helix in the apo-HO-1 molecules is more open, indicating that, although the distal helix is flexible, the open/closed conformation observed in the heme⅐HO-1 structure is most likely a transient state captured in the crystal lattice. This is in agreement with a recent NMR study on human HO-1 that confirmed that parts of the distal helix are probably mobile and that also found a closer approach of the distal helix in human HO-1 than in the crystal structure (40) .
Proximal (His Ligand) Side-A comparison between the two structures in the region surrounding the heme His 25 ligand is shown in Figs. 5 and 6 . The proximal helix in the apo structure is relaxed and moves downwards away from the heme site, accompanied by several conformational changes in the side chains of several residues. In the apo structure, the position of the proximal histidine ligand (His 25 ) moves away from the heme pocket, with the ring adopting random conformations. In the heme⅐HO-1 structure, Glu 29 5 and 6 ). Heme-Protein Interactions-In the heme⅐HO-1 structure, the heme meso edges are buried in the protein, whereas one, the ␦-meso edge, is exposed. The ␣-meso edge of the heme, which is selectively targeted for hydroxylation in the HO reaction, faces a wall of hydrophobic residues in the protein interior consisting of Phe 214 , Met 34 , and Phe 37 ( Figs. 7 and 8 ). In the apo structure, these residues remain relatively unchanged. On the opposite side of the heme, a number of ionic/H-bonding interactions between the heme propionates and nearby side chains are important for orientating the heme in the active site. Basic residues Arg 183 , Lys 18 , and Lys 22 surround the propionates and hold the heme in place in the heme⅐HO-1 structure (Figs. 7 and  8 ). In the apo structure, Lys 179 is unchanged in all molecules; the NH and NH 2 nitrogens of Arg 183 point away from the heme site in molecules A and D, whereas, because of the movement of the proximal helix, Lys 18 and Lys 22 have markedly shifted away from the heme pocket in all four molecules, with the side chain of Lys 22 bent farther away in molecule D than in molecules A-C. The ␤-edge of the heme is in contact with Tyr 134 and Thr 135 in the heme⅐HO-1 structure. The conformations of these residues are distinctly different in the apo structure. The aromatic ring clearly leans away from the heme site and tilts in the direction of the heme propionates. This change correlates with movement of Thr 135 in all four apo-HO-1 molecules, flipping the side chain by ϳ150°such that it points toward the position of the heme ␤-meso-carbon of the heme⅐HO-1 structure.
DISCUSSION
The human apo-HO-1 structure supports our initial findings of a dynamic active-site pocket (21) and is structurally similar to the recently reported rat apo-HO-1 crystal structure (22) . In the comparisons between the apo-HO-1 and heme⅐HO-1 structures that follow, we include the homologous rat HO-1 structures.
Differences in the Distal Pocket-Differences between the apo-HO-1 and heme⅐HO-1 structures are confined to the hemebinding pocket. Interactions of backbone atoms of Gly 139 and Gly 143 in the distal helix that contact the distal water ligand of the heme in the holo-HO-1 structure are no longer present in the apo-HO-1 structure, thus freeing the distal helix to move away from the heme site in all four molecules, closely resembling the open conformation (molecule B) in the human heme⅐HO-1 structure. The absence of a bond between His 25 and the heme iron in the apo structure enables a relaxation of the proximal helix and, combined with the upward movement of the distal helix, increases the overall size of the apo active-site pocket. The larger pocket in the apo-HO-1 structure is reflected by the solvent-accessible volume of 57.9 A 3 , whereas the corresponding volume for the human heme⅐HO-1 structure is 43.6 A 3 (21) . The rat apo-HO-1 and heme⅐HO-1 structures reveal very similar changes (24) . Not surprisingly, because the sequence homology between the two HO-1 proteins is Ͼ80% (5), a comparison of human and rat apo-HO-1 reveals that their overall structures are very similar, excluding the loop region between Leu 141 and Glu 162 (Fig. 9A) . The r.m.s. deviation between molecules A of the two sets of apo structures is 1.11 Å.
Differences in the Proximal Pocket-In the rat apo-HO-1 structure, a large portion of the proximal helix (residues [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] , which includes the proximal heme ligand (His 25 ), is not visible (24) . In the human apo-HO-1 structure, the same region is clearly visible, with the proximal histidine pulled away from the heme pocket. In both the rat and human structures, the H-bonding interaction between the N-⑀ atom of Gln 38 and the carbonyl oxygen of the backbone of Glu 29 observed in the holo structures is lost in the apo form, allowing Gln 38 to adopt a different conformation in the apo structures. Gln 38 appears to be quite flexible because the side chain adopts different confor- 
